BNGO
Bionano Genomics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.11
-0.01 ▼ -0.89%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$1.10
-0.01 ▼ -0.90%
| Index | - | P/E | - | EPS (ttm) | -15.53 | Insider Own | 7.1% | Shs Outstand | 0.01B | Perf Week | -0.89% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 59.97% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -2.63% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -2.48 | Inst Own | 14.65% | Short Float | 12.34% | Perf Quarter | -33.93% |
| Income | -0.04B | P/S | 0.39 | EPS this Y | 92.74% | Inst Trans | 1.26% | Short Ratio | 6.06 | Perf Half Y | -72.66% |
| Sales | 0.03B | P/B | 0.22 | EPS next 5Y | 77.38% | ROA | -46.37% | Short Interest | 1.17M | Perf YTD | -27.45% |
| Book/sh | 5.12 | P/C | 0.35 | EPS past 3/5Y | 17.51% 40.63% | ROE | -78.22% | 52W High | -79.82% ($5.50) | Perf Year | -66.57% |
| Cash/sh | 3.13 | P/FCF | - | Sales past 3/5Y | 19.62% 24.89% | ROIC | -69.04% | 52W Low | 4.72% ($1.06) | Perf 3Y | -99.85% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 88.8% | Gross Margin | 45.97% | Volatility(W/M) | 2.97% 4.26% | Perf 5Y | -99.98% |
| Dividend TTM | - | EV/Sales | -0.12 | Sales Y/Y TTM | -13.84% | Oper. Margin | -122.93% | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.82 | EPS Q/Q | 94.85% | Profit Margin | -134.36% | RSI (14) | 36.9 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.12 | Sales Q/Q | 21.31% | SMA20 | -1.9% ($1.13) | Beta | 1.67 | Target Price | $5.5 |
| Payout | - | Debt/Eq | 0.35 | Earnings | 3000000 | SMA50 | -15.41% ($1.31) | Rel Volume | 0.37 | Prev Close | $1.12 |
| Employees | 100 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | 1.69% 6.68% | SMA200 | -51.66% ($2.3) | Avg Volume(3M) | 0.19M | Price | $1.11 |
| IPO | 2018/9/21 | Option/Short | No/Yes | Trades | 314 | Volume | 70,734 | Change | -0.89% |
뉴스 로딩 중...